HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Retrospective analysis of factors associated with outcome in veno-venous extra-corporeal membrane oxygenation.

AbstractBACKGROUND:
The outcome of Veno-Venous Extracorporeal Membrane Oxygenation (VV-ECMO) in acute respiratory failure may be influenced by patient-related factors, center expertise and modalities of mechanical ventilation (MV) during ECMO. We determined, in a medium-size ECMO center in Switzerland, possible factors associated with mortality during VV-ECMO for acute respiratory failure of various etiologies.
METHODS:
We retrospectively analyzed all patients treated with VV-ECMO in our University Hospital from 2012 to 2019 (pre-COVID era). Demographic variables, severity scores, MV duration before ECMO, pre and on-ECMO arterial blood gases and respiratory variables were collected. The primary outcome was ICU mortality. Data were compared between survivors and non-survivors, and factors associated with mortality were assessed in univariate and multivariate analyses.
RESULTS:
Fifty-one patients (33 ARDS, 18 non-ARDS) were included. ICU survival was 49% (ARDS, 39%; non-ARDS 67%). In univariate analyses, a higher driving pressure (DP) at 24h and 48h on ECMO (whole population), longer MV duration before ECMO and higher DP at 24h on ECMO (ARDS patients), were associated with mortality. In multivariate analyses, ECMO indication, higher DP at 24h on ECMO and, in ARDS, longer MV duration before ECMO, were independently associated with mortality.
CONCLUSIONS:
DP on ECMO and longer MV duration before ECMO (in ARDS) are major, and potentially modifiable, factors influencing outcome during VV-ECMO.
AuthorsThomas Orthmann, Zied Ltaief, Jean Bonnemain, Matthias Kirsch, Lise Piquilloud, Lucas Liaudet
JournalBMC pulmonary medicine (BMC Pulm Med) Vol. 23 Issue 1 Pg. 301 (Aug 16 2023) ISSN: 1471-2466 [Electronic] England
PMID37587413 (Publication Type: Journal Article)
Copyright© 2023. BioMed Central Ltd., part of Springer Nature.
Topics
  • Humans
  • Extracorporeal Membrane Oxygenation
  • COVID-19
  • Retrospective Studies
  • Blood Gas Analysis
  • Respiratory Distress Syndrome (therapy)
  • Respiratory Insufficiency (therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: